Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)

被引：0
|
作者：
Yao Ye
Lin Peng
Aurelia Vattai
Eileen Deuster
Christina Kuhn
Christian Dannecker
Sven Mahner
Udo Jeschke
Viktoria von Schönfeldt
Helene H. Heidegger
机构：
[1] Shanghai Jiao Tong University School of Medicine,Department of Gynecology and Obstetrics, Xinhua Hospital
[2] Ludwig-Maximilians University of Munich,Department of Obstetrics and Gynecology, University Hospital
[3] University of Augsburg,Department of Obstetrics and Gynecology, University Hospital
来源：
Journal of Cancer Research and Clinical Oncology | 2020年 / 146卷
关键词：
Cervical cancer; Prostaglandin E; receptor 3 (EP3); Urokinase-type plasminogen activator receptor (uPAR); Plasminogen activator inhibitor type 1 (PAI-1);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2189 / 2203
页数：14
相关论文
共 21 条
  • [1] Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)
    Ye, Yao
    Peng, Lin
    Vattai, Aurelia
    Deuster, Eileen
    Kuhn, Christina
    Dannecker, Christian
    Mahner, Sven
    Jeschke, Udo
    von Schonfeldt, Viktoria
    Heidegger, Helene H.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2189 - 2203
  • [2] The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients
    Heidegger, Helene
    Dietlmeier, Sebastian
    Ye, Yao
    Kuhn, Christina
    Vattai, Aurelia
    Aberl, Caroline
    Jeschke, Udo
    Mahner, Sven
    Kost, Bernd
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (07)
  • [3] Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3
    Yano, T
    Zissel, G
    Muller-Qernheim, J
    Shin, SJ
    Satoh, H
    Ichikawa, T
    FEBS LETTERS, 2002, 518 (1-3) : 154 - 158
  • [4] Construction of Urokinase-Type Plasminogen Activator Receptor-Targeted Heterostructures for Efficient Photothermal Chemotherapy against Cervical Cancer To Achieve Simultaneous Anticancer and Antiangiogenesis
    Hu, Xiaoli
    Mandika, Chetry
    He, Lizhen
    You, Yuanyuan
    Chang, Yanzhou
    Wang, Jing
    Chen, Tianfeng
    Zhu, Xueqiong
    ACS APPLIED MATERIALS & INTERFACES, 2019, 11 (43) : 39688 - 39705
  • [5] Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells
    Nishi, Hirotaka
    Sasaki, Toru
    Nagamitsu, Yuzo
    Terauchi, Fumitoshi
    Nagai, Takeshi
    Nagao, Toshitaka
    Isaka, Keiichi
    ONCOLOGY REPORTS, 2016, 35 (02) : 992 - 998
  • [6] Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E2–EP3 signaling
    Pei Li
    Yuming Zhao
    Lihong Ge
    Stem Cell Research & Therapy, 7
  • [7] Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells
    G O'Callaghan
    J Kelly
    F Shanahan
    A Houston
    British Journal of Cancer, 2008, 99 : 502 - 512
  • [8] Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway
    Yeung, C. L. Au
    Tsang, T. Y.
    Yau, P. L.
    Kwok, T. T.
    ONCOGENE, 2011, 30 (21) : 2401 - 2410
  • [9] Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway
    C L Au Yeung
    T Y Tsang
    P L Yau
    T T Kwok
    Oncogene, 2011, 30 : 2401 - 2410
  • [10] Prostaglandin E2 mediates the late phase of ischemic preconditioning in the heart via its receptor subtype EP4
    Takayasu Kanno
    Naoki Nakagawa
    Tatsuya Aonuma
    Jun-ichi Kawabe
    Koh-ichi Yuhki
    Naofumi Takehara
    Naoyuki Hasebe
    Fumitaka Ushikubi
    Heart and Vessels, 2023, 38 : 606 - 613
123